Fendioksan je antagonist α1-adrenergičkog receptora.[3]

Fendioksan
Nazivi
Preferisani IUPAC naziv
2-(2,6-Dimetoksifenoksi)-N-{[(2R,3R)-3-fenil-2,3-dihidro-1,4-benzodioksin-2-il]metil}etan-1-amin
Identifikacija
3D model (Jmol)
ChemSpider
UNII
  • COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2[C@H](OC3=CC=CC=C3O2)C4=CC=CC=C4
Svojstva
C25H27NO5
Molarna masa 421,49 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Vidi još

уреди

Reference

уреди
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ Quaglia, W; Pigini, M; Tayebati, SK; Piergentili, A; Giannella, M; Marucci, G; Melchiorre, C (1993). „Structure-activity relationships in 1,4-benzodioxan-related compounds. 4. Effect of aryl and alkyl substituents at position 3 on alpha-adrenoreceptor blocking activity”. Journal of Medicinal Chemistry. 36 (11): 1520—8. PMID 8098772. doi:10.1021/jm00063a002.